Business
Why the Mesoblast (ASX:MSB) share price crashed 45% lower today
The Mesoblast limited (ASX: MSB) share price has returned from its trading halt and crashed significantly lower.
In early trade the biotechnology company’s shares are down a massive 45% to $2.08.
Why is the Mesoblast share price crashing lower?
Investors have been selling the company’s shares this morning after it provided an update on the randomised controlled trial of its remestemcel-L product in ventilator-dependent patients with moderate to severe acute respiratory distress syndrome (ARDS) due to COVID-19 infection.
According to the release, the Data Safety Monitoring Board (DSMB) has performed a third interim analysis on the trial’s first 180 patients.
The trial was aiming to achieve a primary endpoint of 43% reduction…
-
Noosa News5 hours agoShocking moment Bradley Donald Towle arrested after Bruce Hwy rampage and shooting on Sunshine coast
-
General24 hours agoAustralian Catholics mourning death of Pope Francis
-
General20 hours agoPope Francis, the 266th pope, has died
-
General18 hours agoFounder Schwab quits as World Economic Forum chair